Charliński, G.; Steinhardt, M.; Rasche, L.; Gonzalez-Calle, V.; Peña, C.; Parmar, H.; Wiśniewska-Piąty, K.; Dávila Valls, J.; Olszewska-Szopa, M.; Usnarska-Zubkiewicz, L.;
et al. Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis. Cancers 2024, 16, 1592.
https://doi.org/10.3390/cancers16081592
AMA Style
Charliński G, Steinhardt M, Rasche L, Gonzalez-Calle V, Peña C, Parmar H, Wiśniewska-Piąty K, Dávila Valls J, Olszewska-Szopa M, Usnarska-Zubkiewicz L,
et al. Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis. Cancers. 2024; 16(8):1592.
https://doi.org/10.3390/cancers16081592
Chicago/Turabian Style
Charliński, Grzegorz, Maximilian Steinhardt, Leo Rasche, Veronica Gonzalez-Calle, Camila Peña, Harsh Parmar, Katarzyna Wiśniewska-Piąty, Julio Dávila Valls, Magdalena Olszewska-Szopa, Lidia Usnarska-Zubkiewicz,
and et al. 2024. "Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis" Cancers 16, no. 8: 1592.
https://doi.org/10.3390/cancers16081592
APA Style
Charliński, G., Steinhardt, M., Rasche, L., Gonzalez-Calle, V., Peña, C., Parmar, H., Wiśniewska-Piąty, K., Dávila Valls, J., Olszewska-Szopa, M., Usnarska-Zubkiewicz, L., Gozzetti, A., Ciofini, S., Gentile, M., Zamagni, E., Kurlapski, M., Legieć, W., Vesole, D. H., & Jurczyszyn, A.
(2024). Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis. Cancers, 16(8), 1592.
https://doi.org/10.3390/cancers16081592